I. Eisenstadt Richard's Insider Trades & SAST Disclosures
I. Eisenstadt Richard's most recent trade in Altimmune Inc was a trade of 9,275 Common Stock, par value $0.0001 done . Disclosure was reported to the exchange on Jan. 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern I. Eisenstadt Richard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | Richard Eisenstadt I. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2024 | 9,275 | 42,566 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | I. Eisenstadt Richard | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2024 | 9,275 | 27,825 | - | - | Restricted Stock Units | |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.69 per share. | 30 Jan 2024 | 4,621 | 45,012 (0%) | 0% | 2.7 | 12,430 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard Eisenstadt I. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 30 Jan 2024 | 2,175 | 40,391 (0%) | 0% | 9.8 | 21,315 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 163,200 | 163,200 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | I. Richard Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 58,400 | 58,400 | - | - | Restricted Stock Units | |
| Altimmune Inc | I. Richard Eisenstadt | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 12,500 | 36,335 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | I. Richard Eisenstadt | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 12,500 | 25,000 | - | - | Restricted Stock Units | |
| Altimmune Inc | I. Eisenstadt Richard | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.25 per share. | 29 Dec 2023 | 3,044 | 33,291 (0%) | 0% | 11.3 | 34,245 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.81 per share. | 31 Jul 2023 | 1,825 | 23,835 (0%) | 0% | 2.8 | 5,128 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 24 Mar 2023 | 10,000 | 22,010 (0%) | 0% | 4.3 | 43,140 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 10.21 per share. | 31 Jan 2023 | 1,172 | 12,010 (0%) | 0% | 10.2 | 11,964 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 105,000 | 105,000 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 37,100 | 37,100 | - | - | Restricted Stock Units | |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 12,500 | 37,500 | - | - | Restricted Stock Units | |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 12,500 | 13,866 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.45 per share. | 31 Dec 2022 | 3,028 | 10,838 (0%) | 0% | 16.5 | 49,811 | Common Stock, par value $0.0001 |
| Altimmune Inc | Richard I. Eisenstadt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 6.86 per share. | 31 Jul 2022 | 1,366 | 1,366 (0%) | 0% | 6.9 | 9,371 | Common Stock, par value $0.0001 |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges